ペンシルベニアにおける結腸癌の臨床試験
ペンシルベニア内の拠点で、結腸癌に関する18件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- 他2件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Christiana Care Health System-Concord Health Center, Chadds Ford
- 他8件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- 他2件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- St. Luke's University Health Network ( Site 2014), Easton
- UPMC Hillman Cancer Center ( Site 2024), Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Prehabilitation in High-risk Oncologic Surgery
- Fox Chase Cancer Center - Philadelphia, Philadelphia
被験者募集中
18歳以上 · 全性別 · 2026/09/21更新 · NCT07638410A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Alliance Cancer Specialists, Doylestown
- Penn State Milton S. Hershey Medical Center, Hershey
- University of Pennsylvania, Philadelphia
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- Allegheny General Hospital, Pittsburgh
- Magee-Womens Hospital of UPMC, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Saint Luke's Cancer Center - Allentown, Allentown
- Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
- Geisinger Medical Center, Danville
- 他10件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- 他58件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Shield Post-Approval Study Protocol
- US Digestive Health at Blair, Altoona
- University of Pennsylvania, Philadelphia
- Health Living at Pottstown Medical Specialists, Inc, Pottstown
被験者募集中観察研究健康なボランティア歓迎
45歳〜81歳 · 全性別 · 2026/08/07更新 · NCT06880055A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Sidney Kimmel Cancer Center, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Alliance Cancer Specialists, Wynnewood
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Pittsburg Medical Center (UPCM), Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT07223424SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Penn State Milton S. Hershey Medical Center, Hershey
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。